RPG Life Sciences Limited (RPGLIFE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, RPG Life Sciences Limited (RPGLIFE) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs112.70 Million ≈ $1.22 Million USD) by net assets (Rs5.54 Billion ≈ $59.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see RPGLIFE company net worth for the company's overall valuation and market capitalisation.
RPG Life Sciences Limited - Cash Flow Conversion Efficiency Trend (2005–2026)
This chart illustrates how RPG Life Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
RPG Life Sciences Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RPG Life Sciences Limited ranked by their cash flow conversion efficiency. Explore RPGLIFE cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SAMPYO Cement Co. Ltd
KQ:038500
|
0.061x |
|
Albatron Technology Co Ltd
TWO:5386
|
-0.135x |
|
The Elmet Group Co. Common Stock
NASDAQ:ELMT
|
-0.077x |
|
Akis Gayrimenkul Yatirim Ortakligi AS
IS:AKSGY
|
0.015x |
|
Roma Green Finance Limited Ordinary Shares
NASDAQ:ROMA
|
-0.087x |
|
Zhejiang Kanglongda Special
SHG:603665
|
0.024x |
|
Mativ Holdings Inc.
NYSE:MATV
|
0.039x |
|
Bradespar S.A
SA:BRAP3
|
0.000x |
Annual Cash Flow Conversion Efficiency for RPG Life Sciences Limited (2005–2026)
The table below shows the annual cash flow conversion efficiency of RPG Life Sciences Limited from 2005 to 2026. View RPG Life Sciences Limited stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs6.05 Billion ≈ $65.47 Million |
Rs652.80 Million ≈ $7.06 Million |
0.108x | -26.52% |
| 2025-03-31 | Rs5.31 Billion ≈ $57.37 Million |
Rs778.60 Million ≈ $8.42 Million |
0.147x | -41.70% |
| 2024-03-31 | Rs3.75 Billion ≈ $40.54 Million |
Rs943.60 Million ≈ $10.20 Million |
0.252x | -14.74% |
| 2023-03-31 | Rs3.08 Billion ≈ $33.27 Million |
Rs908.20 Million ≈ $9.82 Million |
0.295x | +16.63% |
| 2022-03-31 | Rs2.56 Billion ≈ $27.66 Million |
Rs647.50 Million ≈ $7.00 Million |
0.253x | -5.96% |
| 2021-03-31 | Rs2.16 Billion ≈ $23.41 Million |
Rs582.70 Million ≈ $6.30 Million |
0.269x | -5.25% |
| 2020-03-31 | Rs1.77 Billion ≈ $19.10 Million |
Rs501.70 Million ≈ $5.43 Million |
0.284x | -0.38% |
| 2019-03-31 | Rs1.60 Billion ≈ $17.36 Million |
Rs457.80 Million ≈ $4.95 Million |
0.285x | +200.68% |
| 2018-03-31 | Rs1.55 Billion ≈ $16.74 Million |
Rs146.80 Million ≈ $1.59 Million |
0.095x | +93.85% |
| 2017-03-31 | Rs1.54 Billion ≈ $16.66 Million |
Rs75.40 Million ≈ $815.42K |
0.049x | -80.08% |
| 2016-03-31 | Rs1.34 Billion ≈ $14.45 Million |
Rs328.10 Million ≈ $3.55 Million |
0.246x | +1660.38% |
| 2015-03-31 | Rs1.25 Billion ≈ $13.54 Million |
Rs-19.70 Million ≈ $-213.05K |
-0.016x | +64.40% |
| 2014-03-31 | Rs1.26 Billion ≈ $13.60 Million |
Rs-55.60 Million ≈ $-601.29K |
-0.044x | -127.36% |
| 2013-03-31 | Rs762.30 Million ≈ $8.24 Million |
Rs123.20 Million ≈ $1.33 Million |
0.162x | -23.92% |
| 2012-03-31 | Rs741.40 Million ≈ $8.02 Million |
Rs157.50 Million ≈ $1.70 Million |
0.212x | +10.23% |
| 2011-03-31 | Rs748.31 Million ≈ $8.09 Million |
Rs144.21 Million ≈ $1.56 Million |
0.193x | -39.62% |
| 2010-03-31 | Rs644.31 Million ≈ $6.97 Million |
Rs205.66 Million ≈ $2.22 Million |
0.319x | -39.17% |
| 2009-03-31 | Rs549.21 Million ≈ $5.94 Million |
Rs288.19 Million ≈ $3.12 Million |
0.525x | -4.46% |
| 2008-03-31 | Rs492.02 Million ≈ $5.32 Million |
Rs270.23 Million ≈ $2.92 Million |
0.549x | +166.15% |
| 2007-03-31 | Rs742.36 Million ≈ $8.03 Million |
Rs153.19 Million ≈ $1.66 Million |
0.206x | +67.70% |
| 2006-03-31 | Rs667.72 Million ≈ $7.22 Million |
Rs82.17 Million ≈ $888.59K |
0.123x | -71.98% |
| 2005-03-31 | Rs150.60 Million ≈ $1.63 Million |
Rs66.13 Million ≈ $715.16K |
0.439x | -- |
About RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. … Read more